AMN082, the first selective metabotropic glutaniate receptor subtype 7 agonist: Activation of receptor signaling via an allosteric site in the transmembrane domain

被引:0
|
作者
Mitsukawa, K [1 ]
Yamamoto, R [1 ]
Nozulak, J [1 ]
Ofner, S [1 ]
Pescott, O [1 ]
Lukic, S [1 ]
Stoehr, N [1 ]
Urwyler, S [1 ]
Kuhn, R [1 ]
Herrling, P [1 ]
Cryan, JF [1 ]
Flor, PJ [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci Res, CH-4002 Basel, Switzerland
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
087
引用
收藏
页码:258 / 258
页数:1
相关论文
共 42 条
  • [1] AMN082, the first selective mGluR7 agonist:: Activation of receptor signaling via an allosteric site in the transmembrane domain modulates stress parameters in vivo
    Flor, PJ
    Vassout, A
    Fendt, M
    Mitsukawa, K
    Jacobson, L
    Yamamoto, R
    Nozulak, J
    Ofner, S
    Pescott, O
    Lukic, S
    Stoehr, N
    Urwyler, S
    Kuhn, R
    Herding, P
    McAllister, K
    van der Putten, H
    Cryan, JF
    NEUROPHARMACOLOGY, 2005, 49 : 244 - 244
  • [2] The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
    Rizzo, Stacey J. Sukoff
    Leonard, Sarah K.
    Gilbert, Adam
    Dollings, Paul
    Smith, Deborah L.
    Zhang, Mei-Yi
    Di, Li
    Platt, Brian J.
    Neal, Sarah
    Dwyer, Jason M.
    Bender, Corey N.
    Zhang, Jean
    Lock, Tim
    Kowal, Dianne
    Kramer, Angela
    Randall, Andrew
    Huselton, Christine
    Vishwanathan, Karthick
    Tse, Susanna Y.
    Butera, John
    Ring, Robert H.
    Rosenzweig-Lipson, Sharon
    Hughes, Zoe A.
    Dunlop, John
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 345 - 352
  • [3] The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat
    Dolan, Sharron
    Gunn, Mark D.
    Biddlestone, Laura
    Nolan, Andrea M.
    BEHAVIOURAL PHARMACOLOGY, 2009, 20 (07): : 596 - 604
  • [4] The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice
    Bahi, Amine
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 101 (02) : 193 - 200
  • [5] A selective metabotropic glutamate receptor 7 agonist:: Activation of receptor signaling via an allosteric site modulates stress parameters in vivo
    Mitsukawa, K
    Yamamoto, R
    Ofner, S
    Nozulak, J
    Pescott, O
    Lukic, S
    Stoehr, N
    Mombereau, C
    Kuhn, R
    McAllister, KH
    van der Putten, H
    Cryan, JF
    Flor, PJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18712 - 18717
  • [6] The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats
    Li, Xia
    Gardner, Eliot L.
    Xi, Zheng-Xiong
    NEUROPHARMACOLOGY, 2008, 54 (03) : 542 - 551
  • [7] Activation of Metabotropic Glutamate Receptor 7 by AMN082 Attenuates the Rewarding Effects of Cocaine and Nicotine in Rats
    Li, Xia
    Stoker, Astrid
    Xi, Zheng-Xiong
    Gardner, Eliot
    Markou, Athina
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 324S - 324S
  • [8] AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice
    Jenda, M.
    Gawel, K.
    Marszalek, M.
    Komsta, L.
    Kotlinska, J. H.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 57 : 166 - 175
  • [9] Metabotropic glutamate receptor 7 (mGluR7) allosteric agonist, AMN082 attenuates the acquisition and expression of cocaine-induced behavioral sensitization in mice
    Małgorzata Jenda
    Kinga Gaweł
    Jolanta H. Kotlińska
    Pharmacological Reports, 2013, 65 (Suppl 1) : 50 - 50
  • [10] mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082
    Pelkey, Kenneth A.
    Yuan, Xiaoqing
    Lavezzari, Gabriela
    Roche, Katherine W.
    McBain, Chris J.
    NEUROPHARMACOLOGY, 2007, 52 (01) : 108 - 117